ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

Commemoration Planned For Heidelberger

February 11, 1983

NTP Board Plans Peer Review Of Bioassay Reports

April 11, 1980

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987

Funding Opportunities: NCI Meeting Scheduled For Applicants Of RFA On Pediatric Consortium

February 27, 1998

Senate Votes To Kill A 10% Cut For NIH; Less Severe Budget Cuts Still Possible

May 26, 1995

NCI Advisory Groups To Be Cut By One-Third

April 22, 1977